NCT00510003View on ClinicalTrials.gov

Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old

PHASE4CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

January 31, 2006

Conditions
Atopic Dermatitis
Interventions
DRUG

Pimecrolimus

Pimecrolimus cream 1 %

Trial Locations (1)

Unknown

Novartis Investigative Site, Madrid

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY